Annual SGA
$23.45 M
+$5.83 M+33.05%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual SGA is $23.45 million, with the most recent change of +$5.83 million (+33.05%) on December 31, 2023.
- During the last 3 years, EWTX annual SGA has risen by +$21.24 million (+961.66%).
- EWTX annual SGA is now at all-time high.
Performance
EWTX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$8.21 M
+$783.00 K+10.54%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly SGA is $8.21 million, with the most recent change of +$783.00 thousand (+10.54%) on September 30, 2024.
- Over the past year, EWTX quarterly SGA has increased by +$2.54 million (+44.90%).
- EWTX quarterly SGA is now at all-time high.
Performance
EWTX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.16 B
-$124.29 M-11.98%
September 30, 2024
Summary
- As of February 7, 2025, EWTX TTM SGA is -$1.16 billion, with the most recent change of -$124.29 million (-11.98%) on September 30, 2024.
- Over the past year, EWTX TTM SGA has dropped by -$1.18 billion (-5208.61%).
- EWTX TTM SGA is now -3302.20% below its all-time high of -$34.15 million.
Performance
EWTX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
EWTX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.0% | +44.9% | -5208.6% |
| 3 y3 years | +961.7% | +44.9% | -5208.6% |
| 5 y5 years | +1704.0% | +44.9% | -5208.6% |
EWTX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +112.7% | at high | +121.8% | -397.5% | at low |
| 5 y | 5-year | at high | +1704.0% | at high | +2821.7% | -3302.2% | at low |
| alltime | all time | at high | +1704.0% | at high | +2821.7% | -3302.2% | at low |
Edgewise Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $8.21 M(+10.5%) | $28.87 M(+9.7%) |
| Jun 2024 | - | $7.43 M(+5.2%) | $26.33 M(+6.7%) |
| Mar 2024 | - | $7.06 M(+14.3%) | $24.68 M(+5.2%) |
| Dec 2023 | $23.45 M(+33.1%) | $6.18 M(+9.0%) | $23.45 M(+3.1%) |
| Sep 2023 | - | $5.67 M(-2.0%) | $22.74 M(+6.1%) |
| Jun 2023 | - | $5.78 M(-0.8%) | $21.44 M(+8.6%) |
| Mar 2023 | - | $5.83 M(+6.6%) | $19.75 M(+12.1%) |
| Dec 2022 | $17.63 M | $5.47 M(+25.2%) | $17.63 M(+10.9%) |
| Sep 2022 | - | $4.37 M(+6.8%) | $15.89 M(+8.0%) |
| Jun 2022 | - | $4.09 M(+10.5%) | $14.72 M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $3.70 M(-0.9%) | $13.23 M(+20.0%) |
| Dec 2021 | $11.03 M(+399.1%) | $3.73 M(+16.8%) | $11.03 M(+29.8%) |
| Sep 2021 | - | $3.20 M(+23.0%) | $8.50 M(+48.9%) |
| Jun 2021 | - | $2.60 M(+73.6%) | $5.71 M(+66.6%) |
| Mar 2021 | - | $1.50 M(+24.2%) | $3.42 M(+55.0%) |
| Dec 2020 | $2.21 M(+69.9%) | $1.21 M(+197.5%) | $2.21 M(+120.0%) |
| Sep 2020 | - | $405.00 K(+27.4%) | $1.00 M(+67.6%) |
| Jun 2020 | - | $318.00 K(+13.2%) | $599.00 K(+113.2%) |
| Mar 2020 | - | $281.00 K | $281.00 K |
| Dec 2019 | $1.30 M | - | - |
FAQ
- What is Edgewise Therapeutics annual SGA?
- What is the all time high annual SGA for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual SGA year-on-year change?
- What is Edgewise Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly SGA year-on-year change?
- What is Edgewise Therapeutics TTM SGA?
- What is the all time high TTM SGA for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM SGA year-on-year change?
What is Edgewise Therapeutics annual SGA?
The current annual SGA of EWTX is $23.45 M
What is the all time high annual SGA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual SGA is $23.45 M
What is Edgewise Therapeutics annual SGA year-on-year change?
Over the past year, EWTX annual SGA has changed by +$5.83 M (+33.05%)
What is Edgewise Therapeutics quarterly SGA?
The current quarterly SGA of EWTX is $8.21 M
What is the all time high quarterly SGA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly SGA is $8.21 M
What is Edgewise Therapeutics quarterly SGA year-on-year change?
Over the past year, EWTX quarterly SGA has changed by +$2.54 M (+44.90%)
What is Edgewise Therapeutics TTM SGA?
The current TTM SGA of EWTX is -$1.16 B
What is the all time high TTM SGA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM SGA is -$34.15 M
What is Edgewise Therapeutics TTM SGA year-on-year change?
Over the past year, EWTX TTM SGA has changed by -$1.18 B (-5208.61%)